Boots Pharmaceuticals
Executive Summary
British parent company Boots plc is considering all options ranging from complete sale to full retention of its U.S. pharmaceutical business, the company says. Boots is understood to have engaged CS/First Boston to explore possible transactions for the company. In the U.S., Boots' biggest seller is Synthroid (levothyroxine)